Sort
23,748 grants matching “melanoma”
Keratinocyte targeted strategies for treatment of cutaneous GVHD
$175,088Yunyan Jennifer Jennifer Zhang · Duke University · R21 · FY2020 · CA
ROLES OF WNT GENES, HOX GENES, AND AUTOTAXIN IN BONE MORPHOGENESIS
$175,055Harvard University (Medical School) · P01 · FY2000 · DK
Cancer Biostatistics (CB)
$175,028Kenneth Michael Boucher · University Of Utah · P30 · FY2022 · CA
UT MD Anderson CCOP Research Base
$175,000University Of Texas Md Anderson Can Ctr · U10 · FY2002 · CA
Development of Novel Inhibitors of Ganglioside Biosynthesis
$175,000Brett E Crawford · Zacharon Pharmaceuticals, Inc. · R44 · FY2010 · CA
Cancer Center Support Grant
$175,000Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells
$174,960Fumito Ito · Roswell Park Cancer Institute Corp · K08 · FY2016 · CA
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells
$174,960Fumito Ito · Roswell Park Cancer Institute Corp · K08 · FY2018 · CA
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells
$174,960Fumito Ito · Roswell Park Cancer Institute Corp · K08 · FY2017 · CA
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells
$174,960Fumito Ito · Roswell Park Cancer Institute Corp · K08 · FY2019 · CA
Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma
$174,939Douglas Grossman · Utah State Higher Education System--University Of Utah · R21 · FY2025 · CA
TUMOR CELL RADIOSENSITIZATION BY ADENOVIRAL-MEDIATED P16
$174,923Introgen Therapeutics, Inc. · R41 · FY2000 · CA
Regulation of brown fat metabolism by the immune receptor PD-L1
$174,820Michael Lawrence Dougan · Massachusetts General Hospital · K08 · FY2017 · DK
Pilot-Trans Network Core
$174,784Meenhard Herlyn · Wistar Institute · U54 · FY2024 · CA
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
$174,780Channing J Der · Univ Of North Carolina Chapel Hill · R21 · FY2015 · CA
Mechanisms of autoimmune thyroid disease and the role of interferon-alpha
$174,731Jennifer Sophie Mammen · Johns Hopkins University · K23 · FY2014 · DK
Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
$174,728Guojun Wang · Florida Atlantic University · R21 · FY2017 · CA
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
$174,720Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2016 · CA
Effects of a Novel Phospho-STAT2 inhibitor for Treatment of Stage IV Melanoma
$174,693Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Core D: Animal Experimentation & Wound Healing
$174,662Thomas S McCormick · Case Western Reserve University · P30 · FY2011 · AR
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies
$174,623Mark E Davis · California Institute Of Technology · U54 · FY2012 · CA
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies
$174,556Mark E Davis · California Institute Of Technology · U54 · FY2011 · CA
Rapid Autopsy
$174,490Jody Elizabeth Hooper · Johns Hopkins University · P30 · FY2022 · CA
Rapid Autopsy
$174,490Jody Elizabeth Hooper · Johns Hopkins University · P30 · FY2024 · CA
Rapid Autopsy
$174,490Jody Elizabeth Hooper · Johns Hopkins University · P30 · FY2023 · CA